SIMARD JOHN (Chief Executive Officer) sold 1.2% of their position (50K shares) of XBIOTECH INC. on the open market
Open‑market sale worth $757.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/22/2021ACC: 0001209191-21-057295
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
-50K
Net shares
Net seller
$757.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−13.47K
Price / share
$15.06
Trade value
$202.91K
% of position
0.3%
9/20/2021
4.17M→4.16M
Common Stock
Direct
Shares
−16.86K
Price / share
$15.24
Trade value
$256.91K
% of position
0.4%
9/21/2021
4.16M→4.14M
Common Stock
Direct
Shares
−19.67K
Price / share
$15.14
Trade value
$297.76K
% of position
0.5%
9/22/2021
4.14M→4.12M
Total
Net shares
−50K
Net value
-$757.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/20/2021 | S · Sale | −13.47K | $15.06 | $202.91K | 0.3% | 4.17M | 4.16M |
| Common Stock Direct | 9/21/2021 | S · Sale | −16.86K | $15.24 | $256.91K | 0.4% | 4.16M | 4.14M |
| Common Stock Direct | 9/22/2021 | S · Sale | −19.67K | $15.14 | $297.76K | 0.5% | 4.14M | 4.12M |
| Total | −50K | -$757.58K | ||||||
Derivative Transactions0
No derivative transactions reported